Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunction
Journal
QJM : monthly journal of the Association of Physicians
Journal Volume
114
Journal Issue
12
Pages
848-856
Date Issued
2022
Author(s)
Wang I.-K.
Yen T.-H.
Hsu S.-P.
Sun Y.
Lien L.-M.
Chang W.-L.
Lai T.-C.
Chen P.-L.
Chen C.-C.
Huang P.-H.
Lin C.-H.
Su Y.-C.
Lin M.-C.
Li C.-Y.
Sung F.-C.
Hsu C.Y.
Taiwan Stroke Registry Investigators
Abstract
OBJECTIVE: This study used the Taiwan Stroke Registry data to evaluate the efficacy and safety of intravenous tissue plasminogen activator (tPA) in treating acute ischemic stroke in patients with renal dysfunction. DESIGN: We identified 3525 ischemic stro
SDGs
Other Subjects
fibrinolytic agent; tissue plasminogen activator; brain ischemia; cerebrovascular accident; complication; fibrinolytic therapy; human; kidney disease; retrospective study; treatment outcome; Brain Ischemia; Fibrinolytic Agents; Humans; Ischemic Stroke; Ki
Type
journal article